- Lidoflazine
drugbox
IUPAC_name = 2- [4- [4,4-bis(4-fluorophenyl)butyl] piperazin-1-yl] -N-(2,6-dimethylphenyl)acetamide
CAS_number = 3416-26-0
ATC_prefix = C08
ATC_suffix = EX01
PubChem = 3926
DrugBank =
C=30 | H=35 | F=2 | N=3 | O=1
molecular_weight = 491.615
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category =
legal_AU =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Lidoflazine is a
piperazine calcium channel blocker . It is a coronary vasodilator with some antiarrhythmic action. Lidoflazine was discovered atJanssen Pharmaceutica in1964 .References
* Schaper WK, Xhonneux R, Jageneau AH., Stimulation of the coronary collateral circulation by lidoflazine (R 7904), Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Nov 4;252(1):1-8.
* Schaper WK, Xhoneux R, Jageneau AH, Janssen PA., The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator, J Pharmacol Exp Ther. 1966 May;152(2):265-74.
Wikimedia Foundation. 2010.